Concepedia
Statistics
Publications
23
Citations
1K
H-Index
16
Active since
1984
Affiliations
Mayo Clinic(Current)
Mayo Clinic in Arizona
WinnMed
Iowa Oncology Research Association
Community Cancer Center
Robert F. Marschke is an author at Mayo Clinic specializing in medicine, oncology, and cancer therapeutics.
Top concepts
MedicineOncologyCancer TherapyPharmacologyPharmacotherapyPathologyCancer ResearchRadiation OncologyClinical TrialsLung Cancer
Publications per year
1984–2011
MC044h, a phase II trial of sorafenib in patients (pts) with metastatic neuroendocrine tumors (NET): A Phase II Consortium (P2C) study
Timothy J. Hobday, Joseph Rubin, Kyle D. Holen et al. · Journal of Clinical Oncology · 2007 · 175 citations
Metastatic Net, Primary Endpoint, Pathology +19
A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
T Buroker, C G Moertel, Thomas R. Fleming et al. · Journal of Clinical Oncology · 1985 · 118 citations
Oncology, Biochemical Modulation, Pala Combinations +15
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma
Jeffrey T. Schleusener, Henry D. Tazelaar, Sin‐Ho Jung et al. · Cancer · 1996 · 107 citations · Full text
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
James A. Bonner, William L. McGinnis, Philip J. Stella et al. · PubMed · 1998 · 68 citations
A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer
Elisabeth I. Heath, Melvin Gaskins, Henry C. Pitot et al. · Clinical Prostate Cancer · 2005 · 58 citations
Urology, Oncology, Phase Ii Trial +6
1–5 of 23